The biotech startup EraCal Therapeutics Ltd. develops a novel anti-obesity drug with superior efficacy and safety in zebrafish, mice, and rats compared to the standard of care. Our zebrafish-based phenotypic platform enabled new target discovery and is applicable to other indications.

Cooperation possibilities

In vivo drug discovery and/or validation, CNS active compounds, small molecule chemistry.

Location

Wagistrasse 13, Schlieren, Switzerland

Facts & figures
  • Type of organization

    Private company

  • Year of foundation

    2018

  • Number of employees in Switzerland

    1-9

Key business